EnteroMedics inks collaborative deal with Galvani Bioelectronics

EnteroMedics inked a collaborative deal with Galvani Bioelectronics, a joint venture between GlaxoSmithKline and Verily Life Sciences, under which Galvani will use a modified vBloc system for pre-clinical research. EnteroMedics will receive payments and retain IP ownership.

“EnteroMedics said today it inked a collaborative deal with Galvani Bioelectronics, a joint venture between GlaxoSmithKline and Alphabet's Verily Life Sciences.”massdevice.com

• 1 source
• massdevice.comEnteroMedics inks deal with Verily-GSK JV Galvani Bioelectronics - MassDeviceFink DensfordJul 26, 2017

Summarized from public sources; check the original articles before acting on it.